ALLO icon

Allogene Therapeutics
ALLO

Overview Fund Activity

155 hedge funds and large institutions have $460M invested in Allogene Therapeutics in 2024 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 60 increasing their positions, 47 reducing their positions, and 27 closing their positions.

Holders
155
Holders Change
-18
Holders Change %
-10.4%
% of All Funds
2.24%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
10
Increased
60
Reduced
47
Closed
27
Calls
$354K
Puts
$399K
Net Calls
-$45K
Net Calls Change
-$120K

Top Buyers

1
LCM
1
Lynx1 Capital Management
Puerto Rico
$17.4M
2
Citadel Advisors
2
Citadel Advisors
Florida
$14.1M
3
ECM
3
ExodusPoint Capital Management
New York
$4.58M
4
BlackRock
4
BlackRock
New York
$49.8M
5
Goldman Sachs
5
Goldman Sachs
New York
$6.06M

Top Sellers

1
BC
1
Boxer Capital
California
$0
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$84.1M
3
Renaissance Technologies
3
Renaissance Technologies
New York
$1.8M
4
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$13.6M
5
Jacobs Levy Equity Management
5
Jacobs Levy Equity Management
New Jersey
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$84.1M 30,026,956 -1,230,644 -4%
TGA
2
TPG GP A
Texas
$52.4M 18,716,306 – –
BlackRock
3
BlackRock
New York
$49.8M 17,772,745 +1,327,063 +8%
Vanguard Group
4
Vanguard Group
Pennsylvania
$23.3M 8,327,699 +132,033 +2%
State Street
5
State Street
Massachusetts
$19.6M 7,013,083 -655,041 -9%
Capital World Investors
6
Capital World Investors
California
$19.3M 6,896,552 – –
LCM
7
Lynx1 Capital Management
Puerto Rico
$17.4M 6,202,374 +3,974,079 +178%
Primecap Management
8
Primecap Management
California
$15.9M 5,668,260 -1,966 -0%
Citadel Advisors
9
Citadel Advisors
Florida
$14.1M 5,039,594 +2,593,091 +106%
T. Rowe Price Associates
10
T. Rowe Price Associates
Maryland
$13.6M 4,838,743 -951,799 -16%
WP
11
Woodline Partners
California
$12.2M 4,364,300 +5,311 +0.1%
JPMorgan Chase & Co
12
JPMorgan Chase & Co
New York
$11.4M 4,087,506 -37,348 -0.9%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$9.04M 3,227,104 +407,070 +14%
WCM
14
Wildcat Capital Management
New York
$8.18M 2,920,787 – –
FLSM
15
Frazier Life Sciences Management
California
$8.03M 2,867,750 – –
Two Sigma Investments
16
Two Sigma Investments
New York
$7.83M 2,797,970 -162,703 -5%
Dimensional Fund Advisors
17
Dimensional Fund Advisors
Texas
$7.65M 2,730,480 +179,840 +7%
PA
18
Perceptive Advisors
New York
$7.63M 2,725,000 – –
Two Sigma Advisers
19
Two Sigma Advisers
New York
$6.75M 2,410,400 +167,900 +7%
Goldman Sachs
20
Goldman Sachs
New York
$6.06M 2,162,603 +632,556 +41%
VVA
21
Vida Ventures Advisors
Massachusetts
$5.03M 1,798,163 – –
Morgan Stanley
22
Morgan Stanley
New York
$4.82M 1,721,530 -435,432 -20%
ECM
23
ExodusPoint Capital Management
New York
$4.58M 1,634,838 +1,343,724 +462%
VPC
24
Vestal Point Capital
New York
$4.2M 1,500,000 -700,000 -32%
Northern Trust
25
Northern Trust
Illinois
$3.5M 1,248,539 +210,434 +20%
1
2 3 4 5